JUN 08, 2017 5:37 PM PDT

Important Component of Sonic Hedgehog Pathway is ID'ed

WRITTEN BY: Carmen Leitch

Researchers have revealed new details about a cellular signaling cascade that has been under intense study in part because of its many links to human disease, published in Cell Reports. The cascade, a pathway called Sonic Hedgehog, has a role in developmental disorders as well as cancer. The investigators are hopeful that this new information could help the development of therapeutics for those diseases.

It has been known that a molecule called Smoothened moves into a cellular structure called a cilium (shown in the video) and is then able to activate the smoothened pathway. Most cells in the body have a primary cilium, which acts as a sort of antenna for the cell, picking up cues from the environment and helping the cell respond to them in a variety of ways. Cells are able to secrete things, take things up, or move around, for example.

Smoothened is prevented from entering the cilium under typical conditions, which keeps the pathway under control. For this work, the scientists wanted to know how smoothened was getting into the cilium. They found that an enzyme, Phospholipase A2 gets the process going. In addition, the enzyme seems to “supercharge” the signal from the Smoothened.

"We've basically revealed a new layer of regulation of Smoothened trafficking,"  said Stacey Ogden, Ph.D., an associate member of the St. Jude Department of Cell and Molecular Biology. "This is a very hot area of research now, because Smoothened trafficking appears to be a very crucial control point for signaling activity. So, if you can change Smoothened trafficking, you can very easily adjust the amplitude of Sonic Hedgehog signaling."

Ogden explained that these findings could have a clinical impact, since a reduction in the Sonic Hedgehog pathway activity is a common feature of ciliopathies, genetic disorders relating to primary cilia like Joubert syndrome, Bardet-Biedl syndrome and one of the most common genetic disease in the US, polycystic kidney disease. 

This image shows first author Angela Arensdorf, Ph.D., and corresponding author Stacey Ogden, Ph.D., an associate member of the St. Jude Department of Cell and Molecular Biology. / Credit: Peter Barta / St. Jude Children's Research Hospital

On the other side of dysfunction, over activation of the Sonic Hedgehog pathway causes around 30 percent of childhood medulloblastomas, the most common malignant brain tumor in children. Patients are in desperate need of better treatment options; they currently have to confront a host of terrible side effects and underwhelming efficacy.

"One of the drugs now being used to treat medulloblastoma is a Smoothened inhibitor," Ogden explained. "But tumor cells frequently become resistant to this drug and begin to grow again because of mutations in Smoothened that enable it to overcome the drug's inhibition. We want to determine whether drugs to inhibit Phospholipase A2 could reduce Sonic Hedgehog activity in cases where Smoothened becomes insensitive to targeted inhibition.”

Overactivation of the Hedgehog pathway in adults causes basal cell carcinoma, a very common cancer. Hedgehog pathway activation could be encouraging other types of tumors by influencing the tissue in around the tumor, the stroma, to create an environment that promotes growth, Ogden said.

"So Hedgehog pathway inhibitors may be useful in combination therapies with other traditional chemotherapies for other types of solid tumors," she said.

Ogden and her colleagues are continuing to investigate how Smoothened is regulated, and what drugs might affect its activity. Check out her lab in the video above.

Sources: AAAS/Eurekalert! via St. Jude Children’s Research Hospital, Cell Reports

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 29, 2019
Immunology
NOV 29, 2019
Protecting Killer Immune Cells from Themselves
Destroying human cells compromised by viruses and cancer is the name of the game for so-called “killer” cells of the immune system. They employ...
DEC 18, 2019
Drug Discovery & Development
DEC 18, 2019
Stroke Drug Enhances Stem Cell Therapies for Spinal Cord Injuries
Using rat models of spinal cord injuries, Yasuhiro Shiga, MD, PhD, thought treating them with stem cell therapy would point to nowhere but the nature of re...
JAN 19, 2020
Cell & Molecular Biology
JAN 19, 2020
Scientists Create Neuromuscular Organoids That Contract
This work is a breakthrough for the study of neuromuscular diseases including ALS, muscular dystrophy and multiple sclerosis....
JAN 26, 2020
Cell & Molecular Biology
JAN 26, 2020
Using Stem Cells to Treat Chronic Pain
Scientists have used a mouse model to show that human stem cells could be used to engineer neurons that stop pain....
FEB 04, 2020
Immunology
FEB 04, 2020
The Gut Deploys Protective Mechanisms in Coordination with Your Mealtime Habits
At mealtime, every mouthful of food contains a possible risk of incoming pathogens to the digestive system. The gut takes protective measures to account fo...
FEB 18, 2020
Cell & Molecular Biology
FEB 18, 2020
How Too Much Fluoride Can Disrupt Tooth Enamel
You can have too much of a good thing....
Loading Comments...